All Michelle Werner (CEO of Alltrna) articles

  • Transfer,Rna,(abbreviated,Trna,And,Formerly,Referred,To,As,Srna,
    Article

    New tRNA tech aims to rewrite rare disease treatment

    2025-06-09T09:00:34Z

    Alltrna is redefining the future of rare disease treatment with engineered tRNA therapeutics that target genetic mutations - not just individual diseases. CEO Michelle Werner shares how this bold, mutation-driven approach could unlock universal treatments for thousands of patients long overlooked by traditional medicine.